Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older

Pharmacotherapy

Volumn 20, Issue 4, 2000, Pages 405-409

  Kirk, Julienne K ^a   Spangler, John G ^a   Celestino, Frank S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ESTROGEN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; FEMALE; HUMAN; HYSTERECTOMY; IMMOBILIZATION; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; RISK FACTOR; SYMPTOMATOLOGY;

EID: 0034127302     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.5.405.35051     Document Type: Article

References (13)

1. Lindsay R. Osteoporosis: a guide to diagnosis, prevention, and treatment. New York: Raven Press, 1992.
2. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective: how many women have osteoporosis? J Bone Miner Res 1992;7:1005-10.
3. Consensus Panel, Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
4. Lyles KW. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 1993;94:595-600.
5. National Institute of Arthritis and Musculoskeletal Diseases. Osteoporosis education, health promotion, and research. Bethesda, MD: National Institutes of Health, 1991.
6. United States Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996.
7. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-73.
8. American Association of Clinical Endocrinologists Osteoporosis Task Force. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Endocrine Pract 1996;2:155-71.
9. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997;7:390-406.
10. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Washington, DC: Author, 1998.
11. American College of Obstetrics and Gynecology. Hormone replacement therapy Technical bulletin 166. Washington, DC: Author, 1992.
12. Siris E, Miller P, Barrett-Conner E, Abbott T, Sherwood L, Berger M. Design of NORA, the national osteoporosis risk assessment program: a longitudinal US registry of postmenopausal women. Osteoporosis Int 1998;8(suppl 1):S62-9.
13. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736-46.